Open database of authors and journals

Results 1 to 20 of 29 articles found

The efficacy and safety of tadalafil: an update

BJU International (5.4 ), 93, 1276-81. Cite Citations

Tadalafil: a new treatment for erectile dysfunction

BJU International (5.4 ), 91, 466-8. Cite Citations

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1-year, open-label extension study

BJU International (5.4 ), 107, 1110-6. Cite Citations

Tadalafil and vardenafil vs sildenafil: a review of patient-preference studies

BJU International (5.4 ), 103, 1212-7. Cite Citations

Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction

BJU International (5.4 ), 94, 871-7. Cite Citations

Efficacy and safety of tadalafil 5 mg once daily in the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in men aged ≥75 years: integrated analyses of pooled data from multinational, randomized, placebo-controlled clinical studies

BJU International (5.4 ), 119, 793-803. Cite Citations

cDNA microarray analysis of differentially expressed genes in penile tissue after treatment with tadalafil

BJU International (5.4 ), 101, 508-12. Cite Citations

Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials

BJU International (5.4 ), 96, 857-63. Cite Citations

Penile blood pressure is useful to identify candidates for tadalafil treatment in patients with lower urinary tract symptoms

BJU International (5.4 ), 123, 124-129. Cite Citations

The influence of age on treatment outcomes in men with erectile dysfunction treated with two regimens of tadalafil: results of the SURE study

BJU International (5.4 ), 99, 121-6. Cite Citations

Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection

BJU International (5.4 ), 101, 203-10. Cite Citations

Tamsulosin and placebo vs tamsulosin and tadalafil in male lower urinary tract symptoms: a double-blinded, randomised controlled trial

BJU International (5.4 ), 125, 718-724. Cite Citations

Inhibitory effects of phosphodiesterase 5 inhibitor, tadalafil, on mechanosensitive bladder afferent nerve activities of the rat, and on acrolein-induced hyperactivity of these nerves

BJU International (5.4 ), 110, E259-66. Cite Citations

The safety profile of tadalafil as prescribed in general practice in England: results from a prescription-event monitoring study involving 16 129 patients

BJU International (5.4 ), 103, 506-14. Cite Citations

Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment

BJU International (5.4 ), 105, 502-7. Cite Citations

Factors associated with ejaculatory and orgasmic dysfunction in men with erectile dysfunction: analysis of clinical trials involving the phosphodiesterase type 5 inhibitor tadalafil

BJU International (5.4 ), 109, 1060-7. Cite Citations

An observational cohort study investigating the cardiovascular safety of tadalafil when prescribed in primary care in England: mortality due to ischaemic heart disease

BJU International (5.4 ), 99, 387-93. Cite Citations

Effect of tadalafil 5 mg on post-micturition dribble in men with lower urinary tract symptoms: a multicentre, double-blind, randomized, placebo-controlled trial

BJU International (5.4 ), 124, 862-869. Cite Citations

Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment

BJU International (5.4 ), 118, 153-60. Cite Citations

Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction

BJU International (5.4 ), 112, 990-7. Cite Citations
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and citations
Narrow Search
For searching the publication of a single author or in a journal or in a discipline, find the target category from Authors, Journals, Disciplines, respectively.
Search Engines